Abbott India Bruttó árrés
Mi az Abbott India Bruttó árrés?
A Bruttó árrés az Abbott India Limited - 45.77%
Mi a Bruttó árrés meghatározása?
A bruttó árrés az árbevétel és az eladott áruk költségének különbsége, osztva bevételekkel, és százalékban kifejezve.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Bruttó árrés a Health Care szektor a NSE-on cégekben a Abbott India -hoz képest
Mit csinál Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
bruttó árrés -hoz hasonló cégek Abbott India
- MS Industrie AG nak Bruttó árrés 45.73% van
- NextEra Partners LP nak Bruttó árrés 45.73% van
- Jubilant Industries nak Bruttó árrés 45.74% van
- Dickson Concepts (International) nak Bruttó árrés 45.74% van
- Restore Plc nak Bruttó árrés 45.75% van
- Fusen Pharmaceutical nak Bruttó árrés 45.76% van
- Abbott India nak Bruttó árrés 45.77% van
- Daseke Inc nak Bruttó árrés 45.79% van
- Steadfast nak Bruttó árrés 45.80% van
- Kennametal India nak Bruttó árrés 45.80% van
- Viva China nak Bruttó árrés 45.80% van
- Conoco Phillips nak Bruttó árrés 45.81% van
- The a2 Milk nak Bruttó árrés 45.81% van